SILO — Silo Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- $3.69m
- -$3.06m
- $0.07m
- 39
- 24
- 32
- 23
Annual cashflow statement for Silo Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.01 | -3.04 | 3.9 | -3.91 | -3.7 |
| Amortisation | |||||
| Non-Cash Items | 0.301 | 1.97 | -6.89 | 0.486 | 0.177 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.082 | -0.087 | 0.705 | -0.075 | 0.299 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.794 | -1.16 | -2.28 | -3.5 | -3.22 |
| Other Investing Cash Flow Items | 0.187 | 0.039 | 7.19 | 0.087 | -4.15 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.187 | 0.039 | 7.19 | 0.087 | -4.15 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.383 | 2.13 | 3.79 | 4.94 | -0.471 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.225 | 1.02 | 8.71 | 1.53 | -7.84 |